1. Home
  2. DNTH vs SVM Comparison

DNTH vs SVM Comparison

Compare DNTH & SVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNTH
  • SVM
  • Stock Information
  • Founded
  • DNTH 2015
  • SVM N/A
  • Country
  • DNTH United States
  • SVM Canada
  • Employees
  • DNTH N/A
  • SVM N/A
  • Industry
  • DNTH Biotechnology: Pharmaceutical Preparations
  • SVM Precious Metals
  • Sector
  • DNTH Health Care
  • SVM Basic Materials
  • Exchange
  • DNTH Nasdaq
  • SVM Nasdaq
  • Market Cap
  • DNTH 657.0M
  • SVM 769.7M
  • IPO Year
  • DNTH N/A
  • SVM N/A
  • Fundamental
  • Price
  • DNTH $19.59
  • SVM $3.85
  • Analyst Decision
  • DNTH Strong Buy
  • SVM Strong Buy
  • Analyst Count
  • DNTH 8
  • SVM 1
  • Target Price
  • DNTH $54.33
  • SVM $5.10
  • AVG Volume (30 Days)
  • DNTH 251.8K
  • SVM 5.7M
  • Earning Date
  • DNTH 05-16-2025
  • SVM 05-22-2025
  • Dividend Yield
  • DNTH N/A
  • SVM 0.65%
  • EPS Growth
  • DNTH N/A
  • SVM 104.66
  • EPS
  • DNTH N/A
  • SVM 0.36
  • Revenue
  • DNTH $6,235,000.00
  • SVM $266,463,000.00
  • Revenue This Year
  • DNTH N/A
  • SVM $38.08
  • Revenue Next Year
  • DNTH N/A
  • SVM $1.71
  • P/E Ratio
  • DNTH N/A
  • SVM $10.71
  • Revenue Growth
  • DNTH 120.63
  • SVM 28.94
  • 52 Week Low
  • DNTH $13.37
  • SVM $2.87
  • 52 Week High
  • DNTH $32.27
  • SVM $5.32
  • Technical
  • Relative Strength Index (RSI)
  • DNTH 45.90
  • SVM 54.00
  • Support Level
  • DNTH $20.76
  • SVM $3.63
  • Resistance Level
  • DNTH $22.14
  • SVM $3.86
  • Average True Range (ATR)
  • DNTH 1.50
  • SVM 0.16
  • MACD
  • DNTH -0.13
  • SVM 0.01
  • Stochastic Oscillator
  • DNTH 5.53
  • SVM 86.90

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

About SVM Silvercorp Metals Inc.

Silvercorp Metals Inc is a mineral mining company. It acquires, explores, develops, and mines precious and base metal mineral properties at its producing mines and exploration and development projects in China. The group produces silver, gold, lead, and zinc. The company creates shareholder's value by focusing on generating free cash flow from long-life mines; organic growth through extensive drilling for discovery; equity investments in potential world-class opportunities; ongoing merger and acquisition efforts to unlock value; and long-term commitment to responsible mining and ESG. The Company's producing mines are located in China, and current exploration and development projects are located in China and Mexico.

Share on Social Networks: